5 Best Scientific Instruments Stocks To Buy

1. Thermo Fisher Scientific Inc. (NYSE:TMO)

Number of Hedge Fund Holders: 92

Thermo Fisher Scientific Inc. (NYSE:TMO) provides a range of solutions and products in the life sciences, analytical instruments, specialty diagnostics, and laboratory fields, both in the US and internationally. The company serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best scientific instruments stocks to consider. 

On April 27, Citi analyst Patrick Donnelly maintained a Buy rating on Thermo Fisher Scientific Inc. (NYSE:TMO) but lowered the price target on the shares from $700 to $650  following the Q1 results. The analyst stated that Thermo Fisher Scientific Inc. (NYSE:TMO) recognized some hesitation among bioprocessing customers but to a smaller extent than its peers, as its products have less exposure to early-stage biotech and are upstream-focused. However, the firm lowered the price target due to mounting concerns about the end market.

According to Insider Monkey’s fourth quarter database, 92 hedge funds were long Thermo Fisher Scientific Inc. (NYSE:TMO), and Thomas Steyer’s Farallon Capital is the largest stakeholder of the company, with 1.16 million shares worth approximately $640 million. 

Polen Global Growth Strategy made the following comment about Thermo Fisher Scientific Inc. (NYSE:TMO) in its Q1 2023 investor letter:

“During the quarter, we also raised our position in Thermo Fisher Scientific Inc. (NYSE:TMO). The company effectively sells pickaxes and shovels to the life sciences industry, is well balanced, is durable, and has a strong management team at the helm. We took an initial position recently and are now raising it to an average weight within the Portfolio. During the most recent quarter, the company grew revenue 11% in constant currency. Core organic growth, excluding COVID-19 testing revenue which fell 16%, grew a very strong 13%. This company plays an important role within the Portfolio as a “safety” within our growth spectrum approach and over the next five years we expect EBITDA and EPS to grow at roughly low double digits and low teens, respectively.”

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily enewsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also check out Dividend Aristocrats Ranked: Top 15 According to Analysts and 15 Most Valuable Pre-IPO Companies in The World.